| 期刊ISSN: | 0945-6317 |
|---|---|
| E-ISSN: | 1432-2307 |
| 影响因子: | 3.4 |
| 自引率: | 2.9% |
| 检索数据库: | |
| 出版语言: | 英文 |
| 期刊分类: |
| 最新中科院SCI期刊分区(基础版) | |
|---|---|
|
大学学科
|
|
|
医学
三区
|
|
|
按学科分区
|
|
|
病理学
二区
|
|
|
Top期刊
否
|
|
|
综述期刊
否
|
|
| 最新中科院SCI期刊分区(升级版) | |
|---|---|
|
大学学科
|
|
|
按学科分区
|
|
|
Top期刊
|
|
|
综述期刊
|
|
| 出版信息 | |
|---|---|
| 出版商 |
Springer Berlin Heidelberg
|
| 期刊官网 | https://www.springer.com/428 |
| 涉及的研究方向 |
医学-病理学
|
| 年文章数 |
0
|
| 是否OA |
否
|
| APC费用 | |
| SCI期刊收录coverage | |
| 期刊简介 | |
|---|---|
|
Manuscripts of original studies reinforcing the evidence base of modern diagnostic pathology, using immunocytochemical, molecular and ultrastructural techniques, will be welcomed. In addition, papers on critical evaluation of diagnostic criteria but also broadsheets and guidelines with a solid evidence base will be considered. Consideration will also be given to reports of work in other fields relevant to the understanding of human pathology as well as manuscripts on the application of new methods and techniques in pathology. Submission of purely experimental articles is discouraged but manuscripts on experimental work applicable to diagnostic pathology are welcomed. Biomarker studies are welcomed but need to abide by strict rules (e.g. REMARK) of adequate sample size and relevant marker choice. Single marker studies on limited patient series without validated application will as a rule not be considered. Case reports will only be considered when they provide substantial new information with an impact on understanding disease or diagnostic practice.
|
|
| Cite Score相关 | |||
|---|---|---|---|
| Cite Score | SJR | SNIP | 排名 |
EI Compendex,Scopus,IEEE Xplore
2026年智能系统控制、优化与应用国际学术会议(ISCOA 2026)985主办
IEEE出版
EI Compendex,Scopus,IEEE Xplore
第二届先进计算与智能机器人应用国际学术会议 (ACIRA 2026)IEEE出版
985主办
EI Compendex,Scopus,IEEE Xplore
第三届大数据分析与人工智能应用国际学术会议(BDAIA 2026)交叉学科
IEEE出版
EI Compendex,Scopus,IEEE Xplore
第二届AI赋能图像处理与计算机视觉技术国际学术研讨会(AIPCVT 2026)IEEE出版
多届检索